Search

Your search keyword '"Queralt Ferrer-Menduiña"' showing total 5 results
Start Over Author "Queralt Ferrer-Menduiña" Topic business.industry
5 results on '"Queralt Ferrer-Menduiña"'

2. Ductal stenting in congenital heart disease with duct dependent pulmonary blood flow

Author

Gemma Giralt-Garcia, Laura Marfil-Godoy, Queralt Ferrer-Menduiña, Gerard Martí-Aguasca, and Pedro Betrián-Blasco

Subjects
medicine.medical_specialty, medicine.anatomical_structure, Heart disease, business.industry, Internal medicine, medicine, Cardiology, Pulmonary blood flow, General Medicine, business, medicine.disease, Duct (anatomy)
Published
2020

3. Ductal stenting and pulmonary artery stenosis

Author

Queralt Ferrer Menduiña, Pedro Betrián Blasco, and Gerard Martí Aguasca

Subjects
Heart Defects, Congenital, medicine.medical_specialty, business.industry, Pulmonary artery stenosis, Treatment outcome, MEDLINE, General Medicine, Pulmonary Artery, medicine.disease, Stenosis, Text mining, Treatment Outcome, Medicine, Humans, Carotid Stenosis, Stenosis, Pulmonary Artery, Stents, Radiology, business
Published
2019

4. Stent ductal y estenosis de arterias pulmonares

Author

Queralt Ferrer Menduiña, Gerard Martí Aguasca, and Pedro Betrián Blasco

Subjects
business.industry, Medicine, Cardiology and Cardiovascular Medicine, business, Nuclear medicine
Published
2020

5. Early versus Conventional Treatment for Patent Ductus Arteriosus in Preterm Infants

Author

Ermengol Coma Redon, Queralt Ferrer Menduiña, Ángeles Linde Sillo, Dimpna C. Albert, Félix Castillo Salinas, and Júlia Candel-Pau

Subjects
Male, Pediatrics, medicine.medical_specialty, Time Factors, Birth weight, Indomethacin, Population, Gestational Age, Risk Assessment, Drug Administration Schedule, Cohort Studies, Treatment and control groups, Ductus arteriosus, medicine, Humans, education, Ductus Arteriosus, Patent, Retrospective Studies, education.field_of_study, Chi-Square Distribution, Dose-Response Relationship, Drug, Descriptive statistics, business.industry, Infant, Newborn, Conventional treatment, Obstetrics and Gynecology, Gestational age, Cardiovascular Agents, Retrospective cohort study, Echocardiography, Doppler, Survival Rate, Treatment Outcome, medicine.anatomical_structure, Pediatrics, Perinatology and Child Health, Female, business, Infant, Premature, Follow-Up Studies
Abstract

Objective After the introduction of a new protocol based on the early treatment with indomethacin for patent ductus arteriosus, the objective of this study was to assess the safety and efficacy of this new practice in comparison with the safety and efficacy of the conventional treatment in a high-risk population. Study Design We conducted a retrospective cohort study including 154 newborns with an average gestational age of 26.4 weeks (1.37 standard deviation) and an average birth weight of 855 g (201.5 standard deviation). A statistically descriptive analysis was performed with SPSS Statistics Pack version 17.0. Results and Conclusions We did not find any statistically significant differences in the clinical features of the two treatment groups, nor in the main efficacy, morbidity, and mortality results.

Published
2012

Catalog

Books, media, physical & digital resources
See catalog results